Evidence map›Paper›PMID 37160995›Full record

ArticleScientific reports2023

Streamlined quantitative analysis of histone modification abundance at nucleosome-scale resolution with siQ-ChIP version 2.0.

Bradley M Dickson, Ariana Kupai, Robert M Vaughan, Scott B Rothbart

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bradley M DicksonDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503, USA. bradley.dickson@vai.org.
Ariana KupaiDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503, USA.
Robert M VaughanDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503, USA.
Scott B RothbartDepartment of Epigenetics, Van Andel Institute, Grand Rapids, MI, 49503, USA. scott.rothbart@vai.org.

Funding

Molecular mechanisms of chromatin and epigenetic regulationR35GM124736 · NIGMS · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2017 to 2021
$2.4M
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis ComplexK00CA245821 · NCI · MICHIGAN STATE UNIVERSITY · PI VAUGHAN, ROBERT MARK · 2021 to 2024
$374k
DNA methylation regulation through the UHRF1 oncoproteinF99CA245821 · NCI · VAN ANDEL INSTITUTE GRADUATE SCHOOL · PI VAUGHAN, ROBERT MARK · 2019 to 2020
$90k
NCI NIH HHS F99 CA245821NCI NIH HHS K00 CA245821NIGMS NIH HHS R35 GM124736
6 · The paper itself

Abstract

We recently introduced an absolute and physical quantitative scale for chromatin immunoprecipitation followed by sequencing (ChIP-seq). The scale itself was determined directly from measurements routinely made on sequencing samples without additional reagents or spike-ins. We called this approach sans spike-in quantitative ChIP, or siQ-ChIP. Herein, we extend those results in several ways. First, we simplified the calculations defining the quantitative scale, reducing practitioner burden. Second, we reveal a normalization constraint implied by the quantitative scale and introduce a new scheme for generating 'tracks'. The constraint requires that tracks are probability distributions so that quantified ChIP-seq is analogous to a mass distribution. Third, we introduce some whole-genome analyses that allow us, for example, to project the IP mass (immunoprecipitated mass) onto the genome to evaluate how much of any genomic interval was captured in the IP. We applied siQ-ChIP to p300/CBP inhibition and compare our results to those of others. We detail how the same data-level observations are misinterpreted in the literature when tracks are not understood as probability densities and are compared without correct quantitative scaling, and we offer new interpretations of p300/CBP inhibition outcomes.

Indexed as

Histone CodeNucleosomesChromatin ImmunoprecipitationChromatin Immunoprecipitation SequencingGenomicsNucleosomes

Identifiers

PMID37160995
PMCPMC10169836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.